[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]
Re: AM-INFO digest 28 "FREE"
Considering Glenn's credentials (-If- his sig is accurate), I feel he
alone has the knowledge to make that analogy and you are, once again,
merely blowing smoke ...
Scott K. McGrath
David E. Y. Sarna wrote:
> comparing free software with drugs is repulsive and offensive. Civilized
> people debating the proprietary of Microsoft's marketing techniques
> ought restrain their personal anger enough to be able to conduct civil
> dialogue. Those who can't should see a psychiatrist.
> David E. Y. Sarna firstname.lastname@example.org
> ObjectSoft Corp. (NASDAQ:OSFT) http://www.objectsoftcorp.com
> 433 Hackensack Ave., Hackensack, NJ 07601
> Tel.: (201) 343-9100 Fax: (201) 343-0056
> > -----Original Message-----
> > From: Glenn T. Livezey [SMTP:email@example.com]
> > Sent: Tuesday, November 11, 1997 11:45 AM
> > To: Multiple recipients of list
> > Subject: Re: AM-INFO digest 28 "FREE"
> > The bait in a trap is "FREE" if you can avoid
> > tripping the trigger. The first sample of drugs on the
> > street are often "FREE". Microsoft, and its wholly or
> > partially owned subsidiaries (other wise known as
> > "business partners") often represent software as
> > "FREE" when its license is built into the price of
> > whatever bundled product the consumer is
> > consciously buying. Where have you been hiding
> > in this age of Marketing (the capital is intentional)?
> > "FREE" is freely used in place of "not directly
> > purchased". And there is nothing "egalitarian"
> > about a tax break, especially when it is worth more
> > than the "FREE" product could be sold for on the
> > open market (ie retail as vs. "street price").
> > Egalitarian implies the lofty moral ground of equal
> > rights. "FREE" often means you can have it if you
> > meet the hidden, delayed or indirect costs of the
> > offer. We may all be equal in the opportunity to
> > accept a "FREE" offer, but we are obviously not
> > equal in our understanding of the ultimate price.
> > Glenn T. Livezey, Ph.D.
> > Director of Perinatal Research
> > Division of Maternal-Fetal Medicine
> > Department of Obstetrics & Gynecology
> > University of Nebraska Medical Center
> > 600 South 42nd Street
> > Omaha, NE 68198-3255
> > Phone- 402-559-8064
> > FAX- 402-559-7126
> > e-mail firstname.lastname@example.org